APP intracellular domain is increased and soluble Aβ is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease
- 30 June 2004
- journal article
- research article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 16 (1), 124-132
- https://doi.org/10.1016/j.nbd.2004.01.009
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Presenilin Redistribution Associated with Aberrant Cholesterol Transport Enhances β-Amyloid ProductionIn VivoJournal of Neuroscience, 2003
- Exchange of N-CoR Corepressor and Tip60 Coactivator Complexes Links Gene Expression by NF-κB and β-Amyloid Precursor ProteinCell, 2002
- Insulin-degrading Enzyme Rapidly Removes the β-Amyloid Precursor Protein Intracellular Domain (AICD)Published by Elsevier BV ,2002
- Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic miceNeurochemistry International, 2001
- A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60Science, 2001
- Use of statins in CNS disordersJournal of the Neurological Sciences, 2001
- Augmented Senile Plaque Load in Aged Female β-Amyloid Precursor Protein-Transgenic MiceThe American Journal of Pathology, 2001
- Non-Aβ Component of Alzheimer's Disease Amyloid (NAC) RevisitedThe American Journal of Pathology, 1999
- Lack of apolipoprotein E dramatically reduces amyloid β-peptide depositionNature Genetics, 1997
- Cholesterol Modulates α-Secretase Cleavage of Amyloid Precursor ProteinPublished by Elsevier BV ,1996